Jove
Visualize
お問い合わせ
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 2022 Aha/acc/hfsa 心不全の管理に関するガイドライン: アメリカン・カレッジ・オブ・カーディオロジー/アメリカン・ハート・アソシエーションの臨床実践ガイドラインに関する合同委員会の報告書
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 2022 Aha/acc/hfsa 心不全の管理に関するガイドライン: アメリカン・カレッジ・オブ・カーディオロジー/アメリカン・ハート・アソシエーションの臨床実践ガイドラインに関する合同委員会の報告書

関連する実験動画

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.8K

2022 AHA/ACC/HFSA 心不全の管理に関するガイドライン: アメリカン・カレッジ・オブ・カーディオロジー/アメリカン・ハート・アソシエーションの臨床実践ガイドラインに関する合同委員会の報告書

    Circulation
    |September 26, 2022
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.2K
    Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents
    05:44

    Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents

    Published on: June 8, 2022

    3.0K

    関連する実験動画

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
    09:04

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

    Published on: March 15, 2016

    9.8K
    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
    08:18

    Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

    Published on: July 27, 2022

    1.2K
    Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents
    05:44

    Performing In Vivo and Ex Vivo Electrical Impedance Myography in Rodents

    Published on: June 8, 2022

    3.0K

    関連する概念動画

    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    21
    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    21
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    25
    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    25
    Heart Failure VII: Nursing Interventions01:30

    Heart Failure VII: Nursing Interventions

    131
    The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
    131
    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    27
    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
    27
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    29
    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    29
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    1.8K
    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    1.8K
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー